A quantum AI research team sponsored by Veterans Recovery Network has filed a patent for “digital DNA” technology designed for use in a proposed network of 300 AI-managed microcities. The project, known as the QAIAx AI City Hall, is registered as a public health clinical trial with the National Institute of Health.

The framework details the construction of decentralised microcities within US federal and military enclaves. These sites will operate on a “90/10 Hybrid Workforce Model,” where 90% of municipal services—including utilities, water recycling, and automated farming—are managed by a quantum-computing cloud, with the remaining 10% overseen by human auditors.

The clinical trial aims to evaluate the impact of these environments on 1,000,000 registered residents, focusing on interventional groups for PTSD, autism spectrum disorders, and substance use. The “digital DNA” technology is intended to map human vitals and motor skills into profiles that can be transferred to humanoid robots or holographic projections.

To support the production of these robots, the project is establishing a raw material pipeline in West Africa and Australia, referred to as “Wakanda AI Metropolis” and “AI Oz.” These hubs are intended to secure bauxite and other materials for robot manufacturing, moving production interests away from traditional supply chains.

The project includes a multi-century licensing model for preserving personal and professional identities within the smart city framework. According to the developers, the initiative offers a legal pathway for the use of humanoid robots and AI agents in a federally registered smart health environment.